Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000889812-00-000779
Filing Date
2000-02-14
Accepted
2000-02-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D SC 13G/A 27159
  Complete submission text file 0000889812-00-000779.txt   29089
Mailing Address 9 DELTA DR LONDONDERRY NH 03053
Business Address 9 DELTA DR LONDONDERRY NH 03053 6034378970
DIATIDE INC (Subject) CIK: 0001011888 (see all company filings)

EIN.: 043078258 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46265 | Film No.: 541320
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O CHASE CAPITAL PARTNERS 380 MADISON AVENUE 12TH FLOOR NEW YORK NY 100147
Business Address C/O CHASE CAPITAL PARTNERS 380 MADISON AVENUE 12TH FLOOR NEW YORK NY 10017 2126223100
CHASE VENTURE CAPITAL ASSOCIATES LLC (Filed by) CIK: 0001106605 (see all company filings)